Pederson R A, Brown J C
Endocrinology. 1976 Sep;99(3):780-5. doi: 10.1210/endo-99-3-780.
Gastric inhibitory polypeptide (GIP) produced a dose-related increase in immunoreactive insulin (IRI) from the perfused isolated rat pancreas. The doses employed were within physiological limits. This effect was glucose-concentration-dependent in that there existed a threshold concentration of glucose above which GIP exerted the insulinotropic action, and that, at a fixed concentration of GIP, increased glucose concentrations stimulated IRI release in more than an additive manner. A biologically active fragment of the GIP molecule was isolated and purified. All criteria have been satisfied that GIP is an insulinotropic hormone.
胃抑制多肽(GIP)可使灌注的离体大鼠胰腺释放的免疫反应性胰岛素(IRI)呈剂量依赖性增加。所使用的剂量在生理范围内。这种作用依赖于葡萄糖浓度,即存在一个葡萄糖阈值浓度,高于此浓度时GIP发挥促胰岛素作用,并且在固定的GIP浓度下,葡萄糖浓度升高以超过相加的方式刺激IRI释放。已分离并纯化出GIP分子的一个生物活性片段。所有标准均已满足,表明GIP是一种促胰岛素激素。